Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000550851 | SCV000632553 | pathogenic | Renal carnitine transport defect | 2023-05-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly152 amino acid residue in SLC22A5. Other variant(s) that disrupt this residue have been observed in individuals with SLC22A5-related conditions (PMID: 23430869), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC22A5 protein function. ClinVar contains an entry for this variant (Variation ID: 460408). This missense change has been observed in individual(s) with primary carnitine deficiency (Invitae). This variant is present in population databases (rs747821417, gnomAD 0.003%). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 152 of the SLC22A5 protein (p.Gly152Asp). |
Ambry Genetics | RCV000623583 | SCV000741241 | likely pathogenic | Inborn genetic diseases | 2016-02-16 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000550851 | SCV002055748 | likely pathogenic | Renal carnitine transport defect | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Giacomini Lab, |
RCV000550851 | SCV002576688 | likely pathogenic | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Baylor Genetics | RCV000550851 | SCV005056771 | likely pathogenic | Renal carnitine transport defect | 2024-03-10 | criteria provided, single submitter | clinical testing |